Michellamines D−F, New HIV-Inhibitory Dimeric Naphthylisoquinoline Alkaloids, and Korupensamine E, a New Antimalarial Monomer, from <i>Ancistrocladus korupensis</i>
Yali F. Hallock(National Cancer Institute), Michael R. Boyd(National Cancer Institute), Klaus-Peter Gulden(National Cancer Institute), Robert J. Gulakowski(National Cancer Institute), Gerhard Bringmann(Johannes Gutenberg University Mainz), Jin‐Rui Dai(National Cancer Institute), Martin Ståhl(Roche (Switzerland)), Kirk P. Manfredi(National Cancer Institute), Manuela Schäffer(National Cancer Institute), Guido François(National Cancer Institute), John H. Cardellina(National Cancer Institute), James B. McMahon(National Cancer Institute)
Cited by 97
Related Papers
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Fluorine in Medicinal Chemistry
|ChemBioChem|2004|1.5k
Intramolecular Hydrogen Bonding in Medicinal Chemistry
|Journal of Medicinal Chemistry|2010|566
Detailed Analysis of Scoring Functions for Virtual Screening
|Journal of Medicinal Chemistry|2001|491